Search Results

You are looking at 1 - 10 of 297 items for :

Clear All

Introduction The development of behavioral addictions (BAs, also referred to as impulse control disorders) in association with dopamine agonists (DAs, commonly used to treat Parkinson’s disease) has been reported ( Dodd et

Open access

extracellular dopamine in the amygdala of freely moving rats. Neurorep. 8 , 2817–2820. Lénárd L. Feeding-related changes in extracellular dopamine in the amygdala of freely moving rats

Restricted access

derived dopamine agonist Parkinsonism & Related Disorders 17 8 , 635 637 . A Bate S J W

Open access

45938 Bjerggaard, C., Fog, J. U., Hastrup, H., Madsen, K., Loland, C. J., Javitch, J. A., Gether, U. (2004) Surface targeting of the dopamine transporter involves discrete epitopes in the

Restricted access

Barron, A. B., Søvik, E., Cornish, J. L. (2010) The roles of dopamine and related compounds in reward-seeking behavior across animal phyla. Front. Behav. Neurosci. 4 , 1

Restricted access
Journal of Radioanalytical and Nuclear Chemistry
Authors: L. Müller, C. Halldin, C. Lundkvist, C. Swahn, C. Foged, H. Hall, P. Karlsson, N. Ginovart, Y. Nakashima, T. Suhara and L. Farde

Abstract  

The use of benzhydryl substituted piperazine derivatives and 3-substituted cocaine analogues as radioligands are compared for in vivo visualization of dopamine transporter by PET.

Restricted access
Journal of Behavioral Addictions
Authors: Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, Edward J. Modestino, Lyle Fried, David Baron, David Siwicki, Eric R. Braverman and Rajendra D. Badgaiyan

Introduction For longer than four decades, there has been an ongoing debate about the role of brain dopamine (DA) in reward and addiction. Nutt, Lingford-Hughes, Erritzoe, and Stokes ( 2015 ) proposed that DA may be central to

Open access

. 386 31 490 McCaman, M. W., Ono, J. K., McCaman, R. E. (1979) Dopamine measurements in molluscan ganglia and neurones using a new, sensitive technique

Restricted access

Introduction Parkinson's disease (PD) is a progressive degenerative disorder of the dopaminergic neurons of substantia nigra (SN). The cardinal biochemical abnormality in PD is the profound deficit in brain dopamine levels, primarily contributing to

Restricted access

. , Kim , S. R. , Ko , H.W. , Bok , E. , Shin , W. H. , Jin , B. K. ( 2017 ) Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease . Exp. Mol. Med. 49

Restricted access